Recell System News Today

The FDA has approved Avita Medical’s premarket approval supplement for the use of its Recell System for the treatment of full-thickness skin defects, according to a press release.Recell, a system which uses a small amount of a patient’s skin to prepare Spray-On Skin Cells, was first FDA-approved in 2018 for the treatment of severe burns. RECELL was limited to treating

By Chris Wack Avita Medical shares were up 13% at $16.60 after the company said the U.S. Food and Drug Administration has approved its premarket approval supplement for the use of its Recell System to treat full-thickness skin defects. The reg... | 10:57am